Loading insider details...
Beta
Latest Form 4 (May 14, 2024): Grant/Award of 1,142,857 ITOS shares, $20.00M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 14, 2024 | iTeos Therapeutics, Inc. (ITOS) | Grant/Award | 1,142,857 | $20.00M |
| Feb 8, 2024 | Tyra Biosciences, Inc. (TYRA) | Grant/Award | 63,412 | $825.0K |
| Jan 25, 2024 | Mirati Therapeutics, Inc. (MRTX) | Disposition to Issuer | 287,866 | n/a |
| Oct 17, 2023 | Tango Therapeutics, Inc. (TNGX) | Purchase | 750,000 | $5.30M |
| Oct 12, 2023 | Tango Therapeutics, Inc. (TNGX) | Sale | 50,000 | $495.5K |
| Aug 16, 2023 | Tango Therapeutics, Inc. (TNGX) | Purchase | 475,000 | $2.45M |
| Oct 14, 2022 | Tango Therapeutics, Inc. (TNGX) | Purchase | 117,000 | $497.7K |
| Oct 7, 2022 | Tango Therapeutics, Inc. (TNGX) | Purchase | 25,606 | $94.0K |
| Dec 21, 2021 | Tyra Biosciences, Inc. (TYRA) | Purchase | 125,000 | $1.64M |
| Sep 17, 2021 | Tyra Biosciences, Inc. (TYRA) | Conversion | 5,698,359 | n/a |